Medicine & Life Sciences
Neoplasms
100%
Prostatic Neoplasms
91%
Imatinib Mesylate
83%
Therapeutics
63%
Gastrointestinal Stromal Tumors
60%
Mutation
57%
Survival
56%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
55%
Acute Myeloid Leukemia
45%
Protein-Tyrosine Kinases
42%
Cell Transplantation
41%
Phosphotransferases
41%
Castration
41%
Drug Therapy
39%
Transplants
36%
Leukemia
34%
Breast Neoplasms
31%
Clinical Trials
29%
Progression-Free Survival
28%
Genes
28%
Allogeneic Cells
27%
Bone Marrow
27%
Androgens
26%
Safety
25%
Docetaxel
25%
MDV 3100
25%
Recurrence
24%
Stem Cells
22%
Proteins
22%
Colorectal Neoplasms
21%
Multiple Myeloma
21%
Confidence Intervals
20%
Graft vs Host Disease
19%
Pharmaceutical Preparations
19%
B-Cell Chronic Lymphocytic Leukemia
19%
Prostate-Specific Antigen
19%
Placebos
18%
Biomarkers
18%
T-Lymphocytes
16%
Hematopoietic Stem Cells
16%
Phosphorylation
16%
Hematologic Neoplasms
16%
Neoplasm Metastasis
16%
Mortality
16%
Cell Line
16%
Adenocarcinoma
15%
Growth
15%
Transplantation
15%
Apoptosis
15%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14%
Thrombosis
14%
Tissue Donors
14%
Hemorrhage
14%
Randomized Controlled Trials
14%
Population
14%
Stem Cell Transplantation
14%
Unrelated Donors
14%
Non-Hodgkin's Lymphoma
14%
Homologous Transplantation
13%
Renal Cell Carcinoma
13%
Sarcoma
13%
Dasatinib
13%
Hematopoietic Stem Cell Transplantation
13%
In Vitro Techniques
13%
Myeloid Cells
13%
Tyrosine
13%
Lymphoma, Large B-Cell, Diffuse
13%
Radiotherapy
12%
Cytogenetics
12%
Prostate
12%
Leukemia, Myeloid, Chronic Phase
12%
pembrolizumab
12%
Calcium-Calmodulin-Dependent Protein Kinase Type 2
12%
Young Adult
11%
Calcitriol
11%
tisagenlecleucel
11%
Gene Expression
11%
Biopsy
11%
Philadelphia Chromosome
11%
Carcinoma
11%
Genome
11%
Mantle-Cell Lymphoma
11%
Sunitinib
11%
Androgen Receptors
11%
Quality of Life
10%
ponatinib
10%
Melanoma
10%
Blood Platelets
10%
B-Lymphocytes
10%
Receptor Protein-Tyrosine Kinases
10%
Lymphoma
10%
Thrombocytopenia
9%
Liver
9%
Incidence
9%
Transcriptome
9%
Anticoagulants
9%
Pancreatic Neoplasms
9%
src Homology Domains
9%
Systematic Reviews
9%